As we discussed above, some of these genes, such as KRT19, EMP1, and PARP2, have evidence from previous studies, which indicate their higher expression levels in the original tumors compared with PDX tumor cells [12,13,52,58]. The gene discussed is EMP1; the disease is neoplasm.